A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma.
about
A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma.Recurrence pattern analysis after re-irradiation with bevacizumab in recurrent malignant glioma patientsConvection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenograftsConvection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft modelCanadian recommendations for the treatment of glioblastoma multiforme.Pharmacotherapy for adults with tumors of the central nervous system.Non-PEGylated liposomes for convection-enhanced delivery of topotecan and gadodiamide in malignant glioma: initial experience.Delayed onset of paresis in rats with experimental intramedullary spinal cord gliosarcoma following intratumoral administration of the paclitaxel delivery system OncoGelValproic acid induced differentiation and potentiated efficacy of taxol and nanotaxol for controlling growth of human glioblastoma LN18 and T98G cells.Synergistic Antitumor Effects of Berbamine and Paclitaxel through ROS/Akt Pathway in Glioma Cells.Evidence and Context of Use for Contrast Enhancement as a Surrogate of Disease Burden and Treatment Response in Malignant Glioma.Mesenchymal stem cells loaded with paclitaxel-poly(lactic--glycolic acid) nanoparticles for glioma-targeting therapy
P2860
Q33391296-160D7156-1BD8-453F-BEBB-88452E367BE6Q35018538-CBD121BC-7C1C-4A62-ABB1-300982E490FDQ35688338-EFF96169-D076-4095-98EF-5F3A49A6166EQ35800657-C315F8F3-6A8A-48FD-815D-45CDCF0322CAQ35855352-D5B43169-28C5-4C6A-801E-4EC4C77EA644Q37353276-81265929-C51B-4134-A1AA-40CC799AFCC6Q37380284-912C4FE4-AC83-400D-BF45-8ED9ABCCD0ADQ37689187-4C3C94C4-2153-4F2D-9918-6B789980BFF9Q39501439-4EB228D0-AFAA-4117-83AB-BA1FFC6EAF01Q41524387-0B31846A-CCD3-4F3B-ABD3-EE98626E1F01Q47436703-472568B9-F499-4158-9F6C-0C37072C7979Q58759012-5C385B1C-2D63-45C9-9558-39EB762C7951
P2860
A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
A Phase II trial of paclitaxel ...... rme or anaplastic astrocytoma.
@ast
A Phase II trial of paclitaxel ...... rme or anaplastic astrocytoma.
@en
type
label
A Phase II trial of paclitaxel ...... rme or anaplastic astrocytoma.
@ast
A Phase II trial of paclitaxel ...... rme or anaplastic astrocytoma.
@en
prefLabel
A Phase II trial of paclitaxel ...... rme or anaplastic astrocytoma.
@ast
A Phase II trial of paclitaxel ...... rme or anaplastic astrocytoma.
@en
P2093
P1476
A Phase II trial of paclitaxel ...... rme or anaplastic astrocytoma.
@en
P2093
C Harker Rhodes
Camilo E Fadul
Carol E McDonnell
J Marc Pipas
James R Rigas
Laurence D Cromwell
Linda S Kingman
Louise P Meyer
P2888
P304
P356
10.1007/S11060-004-2026-2
P577
2005-02-01T00:00:00Z
P6179
1002543680